Company intelligence / Profile preview

Proxylab

Ownership: Private
Development stage: Other

Overview

Proxylab is a Belgian company active since 1999, specializing in the development and sale of scientific products and devices designed for research in molecular and cellular biology. The company serves academic, biotech, pharma, and healthcare researchers by providing laboratory tools rather than developing its own therapeutics or diagnostics. There is no evidence that it operates as a contract research organization (CRO), contract manufacturing organization (CMO), or develops proprietary drug candidates.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on Proxylab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proxylab.

Explore the full profile